Senior Vice President, Late-Stage Clinical Development

The Company is seeking a Senior Vice President of Late-Stage Clinical Development to shape clinical strategy across a growing oncology portfolio. The role leads registrational and Phase 3 programs from trial design through readout and filing support, guiding decisions on indications, endpoints, sequencing, and combination strategies. The executive will develop and lead global development teams, build the late-stage organization, and collaborate with research, regulatory, biometrics, and commercial leaders on integrated portfolio plans. Responsibilities also include supporting global regulatory interactions, representing the organization with clinical collaborators, and engaging investigators and the oncology community. Candidates must hold an MD or MD/PhD and be trained as a medical oncologist, with substantial late-stage oncology development experience and accountability for registrational programs, Phase 3 trials, and global filings. Experience in pancreatic, colorectal, or lung cancer is strongly preferred. Applicants should have a record of leading teams across multiple assets and building clinical development organizations, including hiring and developing program leaders. Strong scientific judgment, senior-level stakeholder alignment, and the ability to operate effectively in a fast-changing environment are essential.